Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Esther Aklilu"'
Autor:
Samantha Sundercombe, Rebecca Walsh, Bernadette Hanna, Noha Elserafy, Edwin Kirk, Futao Zhang, Ying Zhu, Michael Buckley, Esther Aklilu, Tony Roscioli
Publikováno v:
Pathology. 54:S72-S73
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::76a157d66aca44ff84194ee0d8940dd6
https://doi.org/10.1016/j.pathol.2021.12.239
https://doi.org/10.1016/j.pathol.2021.12.239
Autor:
Douglas E. Joshua, Liane Khoo, Esther Aklilu, James Favaloro, Ross Brown, Shihong Yang, P. Joy Ho, Phillip D. Fromm, Derek N.J. Hart, Hayley Suen, John Gibson
Publikováno v:
Leukemia & Lymphoma. 55:1090-1098
Discrepancies in the literature between regulatory T cell (Treg) and pro-inflammatory T helper 17 (Th17) numbers in multiple myeloma (MM) can be largely explained by technical differences in methodology and patient selection. In this study, Treg cell
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6231df2c479509b95c02e8601b4b12f4
https://doi.org/10.3109/10428194.2013.825905
https://doi.org/10.3109/10428194.2013.825905
Autor:
Jia Li, Yuling Chen, Karieshma Kabani, Tetsuo Yamagishi, Warren Kaplan, Daniel Man-Yuen Sze, Ross D. Brown, Suilin Mo, Mark J. Cowley, Yen Siew Loh, P. Joy Ho, Shihong Yang, Douglas E. Joshua, Esther Aklilu
Publikováno v:
Blood. 115:3580-3588
T cells contribute to host-tumor interactions in patients with monoclonal gammopathies. Expansions of CD8+CD57+ T-cell receptor Vβ–positive (TCRVβ+)–restricted cytotoxic T-cell (CTL) clones are found in 48% of patients with multiple myeloma and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d42452d21c858f19fa1660cd1c2bf4c4
https://doi.org/10.1182/blood-2009-10-246991
https://doi.org/10.1182/blood-2009-10-246991
Autor:
Karieshma Kabani, Narelle Woodland, Esther Aklilu, Pj Ho, Regan Brown, Douglas E. Joshua, S Yang, Suzanne Reid
Publikováno v:
International Journal of Laboratory Hematology. 32:e190-e196
Summary Introduction: The use of CD138 to isolate CD138 + plasma cells (PCs) from plasma cell myeloma (PCM) patients’ bone marrow samples has been used extensively in myeloma research. We sought to highlight the problem with this selection process,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::783eeffd592e0f03fc97cf71b6ad2e94
https://doi.org/10.1111/j.1751-553x.2010.01222.x
https://doi.org/10.1111/j.1751-553x.2010.01222.x
Autor:
Andrew Spencer, Nola Kennedy, Phoebe Joy Ho, Ross D. Brown, Douglas E. Joshua, Esther Aklilu, Shihong Yang, Daniel M. Sze, John Gibson, Karieshma Kabani
Publikováno v:
Leukemia and Lymphoma. :1-5
The expanded T cell clones are associated with a prolonged survival in patients with multiple myeloma. We sought to confirm this prognostic significance in a multicenter patient cohort and investigate the effect of thalidomide on clones and T regulat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e97fe28db5319db0e153a6f1e977afd
https://doi.org/10.1080/10428190903216804
https://doi.org/10.1080/10428190903216804
Autor:
Phoebe Joy Ho, Najah T. Nassif, Christian E Bryant, James Favaloro, S Yang, Ross Brown, Derek N.J. Hart, Harry J. Iland, Douglas E. Joshua, Phillip D. Fromm, Narelle Woodland, Hayley Suen, John Gibson, Esther Aklilu
Publikováno v:
Blood Cancer Journal
Despite improved outcomes in multiple myeloma (MM), a cure remains elusive. However, even before the current therapeutic era, 5% of patients survived 410 years and we propose that immune factors contribute to this longer survival. We identified patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8c05ce1ddbce3d54d864aff81f294c9
http://europepmc.org/articles/PMC3789202
http://europepmc.org/articles/PMC3789202
Autor:
Narelle Woodland, Esther Aklilu, Shihong Yang, Christian E Bryant, Phillip D. Fromm, Harry J. Iland, Najah T. Nassif, P. Joy Ho, Hayley Suen, John Gibson, Derek N.J. Hart, James Favaloro, Douglas E. Joshua, Ross D. Brown
Publikováno v:
Blood. 118:3924-3924
Abstract 3924 Prior to the introduction of novel therapies for patients with multiple myeloma (MM) few patients survived for more than 10 years. Several reports have suggested that 10 year survival is associated with a younger age at diagnosis and th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8cae66098cd006433b0f2c73383c70f6
https://doi.org/10.1182/blood.v118.21.3924.3924
https://doi.org/10.1182/blood.v118.21.3924.3924
Autor:
Shihong Yang, Phoebe Joy Ho, Douglas E. Joshua, John Gibson, Karieshma Kabani, Esther Aklilu, Ross D. Brown
Publikováno v:
Blood. 116:983-983
Abstract 983 HLA-G is a “non-classical” HLA class I molecule which is considered to be responsible for the immune tolerance of the fetus, allografts or tumors by inhibiting the antigen-specific cytotoxic T lymphocyte response and decreasing NK ce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::286d5dace4b15738ecdcef8d45b91416
https://doi.org/10.1182/blood.v116.21.983.983
https://doi.org/10.1182/blood.v116.21.983.983
Autor:
Shihong Yang, Yuling Chen, Douglas E. Joshua, Warren Kaplan, Karieshma Kabani, Daniel Sze, Suilin Mo, Esther Aklilu, Phoebe Joy Ho, Jia Li, Tetsuo Yamagishi, Ross D. Brown, Yen Siew Loh, Mark J. Cowley
Publikováno v:
Blood. 114:1820-1820
Abstract 1820 Poster Board I-846 T cells contribute to the immunomodulatory control of the tumor in patients with monoclonal gammopathies. We previously found that CD3+CD8+CD57+TCRVβ+restricted cytotoxic T cell expansions were present in 48% of pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::51ae1f24a19011e8f30f8394cb724511
https://doi.org/10.1182/blood.v114.22.1820.1820
https://doi.org/10.1182/blood.v114.22.1820.1820
Autor:
Brown, Ross D., Kabani, Karieshma *, Yang, Shihong *, Esther, Aklilu *, Ho, Phoebe Joy, Gibson, John, Joshua, Douglas E.
Publikováno v:
In Blood 16 November 2008 112(11):1681-1681